Active Not Recruiting PHASE2 INTERVENTIONAL 3-arm NCT05856448

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus (GALACELA)

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subjects With Active Systemic Lupus Erythematosus

Sponsor: Galapagos NV

Conditions Systemic Lupus Erythematosus

Interventions GLPG3667 Placebo

Updated 23 times since 2023 Last updated: Dec 22, 2025 Started: Jun 28, 2023 Primary completion: Oct 8, 2025 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Systemic Lupus Erythematosus, this trial is ongoing. The trial is conducted by Galapagos NV and has accumulated 23 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

23 versions recorded

Jan 2026 — Present [monthly]

Active Not Recruiting PHASE2
Sep 2025 — Jan 2026 [monthly]

Active Not Recruiting PHASE2
Apr 2025 — Sep 2025 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Feb 2025 — Apr 2025 [monthly]

Recruiting PHASE2
Jan 2025 — Feb 2025 [monthly]

Recruiting PHASE2

▶ Show 18 earlier versions

Dec 2024 — Jan 2025 [monthly]

Recruiting PHASE2
Nov 2024 — Dec 2024 [monthly]

Recruiting PHASE2
Oct 2024 — Nov 2024 [monthly]

Recruiting PHASE2
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE2
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE2
May 2024 — Jun 2024 [monthly]

Recruiting PHASE2
Apr 2024 — May 2024 [monthly]

Recruiting PHASE2
Mar 2024 — Apr 2024 [monthly]

Recruiting PHASE2
Feb 2024 — Mar 2024 [monthly]

Recruiting PHASE2
Jan 2024 — Feb 2024 [monthly]

Recruiting PHASE2
Dec 2023 — Jan 2024 [monthly]

Recruiting PHASE2
Nov 2023 — Dec 2023 [monthly]

Recruiting PHASE2
Oct 2023 — Nov 2023 [monthly]

Recruiting PHASE2
Sep 2023 — Oct 2023 [monthly]

Recruiting PHASE2
Aug 2023 — Sep 2023 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jun 2023 — Aug 2023 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Galapagos NV

Data source: Galapagos NV

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Aventura, United States , Badajoz, Spain , Barcelona, Spain , Batumi, Georgia , Belgrano, Argentina , Budapest, Hungary , Buenos Aires, Argentina , Bytom, Poland , Caba, Argentina and 54 more locations